ÁL
Therapeutic Areas
Tetraneuron Pipeline
| Drug | Indication | Phase |
|---|---|---|
| E2F4-targeted Gene Therapy | Alzheimer's Disease | Pre-clinical |
Leadership Team at Tetraneuron
JM
José M. Frade, PhD
Co-Founder and Chief Scientific Officer
MN
Manuel Nuñez González
Chairman & Co-Founder
ÁP
Álvaro Pascual-Leone, MD, PhD
Chief Medical Officer
MC
Mari Carmen Álvarez, PhD
Managing Director
MM
Mar Municio, PhD
R&D Director
NL
Noelia López Sánchez, PhD
Technical Director